Educational inequalities in blood pressure across the adult life course: Evidence from a 20-year follow-up study

Abstract

Aim:

High blood pressure (BP) is a key contributor to the burden of disease. This study aimed to assess: a) educational differences across the entire BP distribution, and b) educational differences in the trajectories of BP across the adult life course.

Method:

Longitudinal data from the Stockholm Diabetes Prevention Program was analysed using quantile regression and linear mixed effects models. Models were adjusted for age, sex, lifestyle, and BP medication.

Results:

Lower educational level was associated with higher systolic BP (SBP) at all follow-up periods. Age and sex adjusted mean SBP was 2.49 (95% confidence interval (CI) 1.10, 3.87), 3.95 (95% CI 2.45, 5.45) and 2.61 (95% CI 1.09, 4.13) mmHg higher for people with pre-secondary education compared with post-secondary at baseline, 10 years and 20 years follow-up, respectively. Quantile regressions revealed that the inequalities could be observed across the entire BP continuum. Longitudinally analysed, people with pre-secondary education had 3.01 (95% CI 1.91–4.11) mmHg higher SBP than those with post-secondary education, age and sex adjusted. No significant convergence or divergence of the educational gaps in SBP was observed. Educational differences remained even after adjusting for lifestyle and BP medication.

Conclusions:

These results imply that public health interventions should aim to bring about distributional shifts in blood pressure, rather than exclusively focusing on hypertensive people, if they are to effectively minimize the educational disparities in blood pressure and its consequences.

Keywords

Blood pressure education health inequalities quantile regression longitudinal data mixed effects analysis

Get full access to this article

View all access options for this article.

References

Singh

Danaei

Farzadfar

, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis. PLoS One 2013;8:e65174.

Murray

CJL

Aravkin

Zheng

, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1223–49.

Institute for Health Metrics and Evaluation (IHME). GBD compare data visualization. Seattle, WA: IHME, University of Washington, http://vizhub.healthdata.org/gbd-compare (2020, accessed 20 December 2020).

Lawes

Hoorn

Law

, et al. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens 2006;24:423–30.

Poulter

Prabhakaran

Caulfield

Hypertension. Lancet 2015;386:801–12.

Law

Morris

Wald

NJ.

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.

Rose

Sick individuals and sick populations. Int J Epidemiol 2001;30:427–32. DOI: 10.1093/ije/30.3.427.

Eriksson

Carlberg

Pennlert

, et al. Time trends and socioeconomic differences in blood pressure levels: The Northern Sweden MONICA study 1994–2014. Eur J Prev Cardiol 2017;24:1473–81.

Grotto

Huerta

Sharabi

Hypertension and socioeconomic status:

Curr Opin Cardiol 2008;23:335–9.

10.

Degerlund Maldi

San Sebastian

Gustafsson

, et al. Widespread and widely widening? Examining absolute socioeconomic health inequalities in northern Sweden across twelve health indicators. Int J Equity Health 2019;18:197.

11.

Leng

Jin

, et al. Socioeconomic status and hypertension: A meta-analysis. J Hypertens 2015;33:221–9.

12.

Bann

Fluharty

Hardy

, et al. Socioeconomic inequalities in blood pressure: Co-ordinated analysis of 147,775 participants from repeated birth cohort and cross-sectional datasets, 1989 to 2016. BMC Med 2020;18:338.

13.

Carlberg

Weinehall

, et al. Trends of blood pressure levels and management in Västerbotten County, Sweden, during 1990–2010. Glob Health Action 2012;5:18195.

14.

Wang

Kong

, et al. Independent associations of education, intelligence, and cognition with hypertension and the mediating effects of cardiometabolic risk factors: A mendelian randomization study. Hypertension 2023;80:192–203.

15.

Bruno

Amaradio

Pricoco

, et al. Lifestyle and hypertension: An evidence-based review. J Hypertens Manag. Epub ahead of print 31 December 2018. DOI: 10.23937/2474-3690/1510030

16.

Clouston

SAP

Rubin

Phelan

, et al. A social history of disease: Contextualizing the rise and fall of social inequalities in cause-specific mortality. Demography 2016;53:1631–56.

17.

Gudjonsdottir

Tynelius

Fors

, et al. Cohort profile: The Stockholm Diabetes Prevention Programme (SDPP). Int J Epidemiol 2022;51:e401-13.

18.

Flint

Conell

Ren

, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med 2019;381:243–51.

19.

Koenker

Bassett

Regression quantiles. Econometrica 1978;46:33.

20.

Bann

Fitzsimons

Johnson

Determinants of the population health distribution: An illustration examining body mass index. Int J Epidemiol 2020;49:731–7.

21.

Gelman

Scaling regression inputs by dividing by two standard deviations. Stat Med 2008;27:2865–73.

22.

Koenker

Quantile regression. Cambridge: Cambridge University Press, 2005

23.

bates

mächler

bolker

, et al. fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1–48. DOI: 10.18637/jss.v067.i01

24.

Lüdecke

ggeffects: Tidy data frames of marginal effects from regression models. J Open Source Softw 2018;3:772.

25.

Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: An individual participant-level data meta-analysis. Lancet 2021;397:1625–36.

26.

Wolf-Maier

Cooper

Kramer

, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10–7.

27.

Mosquera

San Sebastian

Waenerlund

A-K

, et al. Income-related inequalities in cardiovascular disease from mid-life to old age in a Northern Swedish cohort: A decomposition analysis. Soc Sci Med 2016;149:135–44.

28.

Lundberg

. The next step towards more equity in health in Sweden: How can we close the gap in a generation? Scand J Public Health 2018;46:19–27. DOI: 10.1177/1403494818765702.

29.

Ljungman

Kahan

Schiöler

, et al. Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: The Swedish Primary Care Cardiovascular Database (SPCCD). J Hum Hypertens 2015;29:385–93.

30.

Mackenbach

JP.

Should we aim to reduce relative or absolute inequalities in mortality?

Eur J Public Health 2015;25:185.

31.

Gorostidi

Vinyoles

Banegas

, et al. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res 2015;38:1–7.

32.

Guirguis-Blake

Evans

Webber

, et al. Screening for hypertension in adults: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325:1657.

33.

Eriksson

A-K

Ekbom

Hilding

, et al. The influence of non-response in a population-based cohort study on type 2 diabetes evaluated by the Swedish Prescribed Drug Register. Eur J Epidemiol 2012;27:153–62.

34.

Marmot

Health equity in England: The Marmot review 10 years on. BMJ 2020;368:m693.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

3.37 MB